Logo Logo Logo Logo Logo
  • Home
  • About
    • Management team
    • Board of directors
    • Scientific and Clinical Advisors
  • Products
    • Mitral Valve Disease
  • Media
    • Publications
  • Contact
  • Home
  • About
    • Management team
    • Board of directors
    • Scientific and Clinical Advisors
  • Products
    • Mitral Valve Disease
  • Media
    • Publications
  • Contact

Media

Press releases and congress presentations

Medtentia Helix Ring for Mitral Valve Repair Shows Promising Results
26.10.2021
Medtentia Reaches Major R&D Milestones
8.2.2021
Medtentia to Present at ICI for All Global Digital Summit
4.12.2020
Medtentia to Present at PCR London Valves E-Course
20.11.2020
Medtentia CEO to Present at the Nordic-American Life Science Investment and Partnering Conference
11.11.2020
Medtentia to Present Data at ICI Meeting
6.12.2019
FDA grants Breakthrough Device designation to CathHELIX®, Medtentia’s catheter-based mitral valve repair device
25.9.2019
Medtentia to Present Data at Leading Scientific Conference, TCT 2017
15.10.2017
Medtentia to Present at 2017 PCR Innovators Day
17.9.2017
Medtentia to Present Trial Data at the Heart Valve Society Scientific Meeting 2017
27.2.2017
Clinical Study Results Reveal Improved Heart Condition with Medtentia Annuloplasty Ring (MAR)
17.10.2016
Hannu Syrjälä Appointed as New Chairman for Medtentia’s Board of Directors
27.9.2016
Data Collection Completed for the Clinical Study Evaluating Medtentia Annuloplasty Ring Safety and Performance
22.8.2016
Medtentia Raises €8M in New Financing Round
30.11.2015
Medtentia Helix Ring for Mitral Valve Repair Continues to Achieve All Objectives in Approval Study
31.7.2013
Get in touch

Medtentia International Ltd Oy
Upseerinkatu 1, tower 1
02600 Espoo, Finland

 

Olli Keränen
Chief Executive Officer
mobile: +358 50 3567090
ok@medtentia.com

© Medtentia International Ltd Oy